乳腺癌的基因治疗
Gene therapy of breast cancer
出处
《中国实用外科杂志》
CSCD
北大核心
2003年第10期586-589,共4页
Chinese Journal of Practical Surgery
参考文献13
-
1王劲松,王深明,陈国锐,杨大俊.免疫毒素与顺铂协同杀伤肿瘤细胞机制的探讨[J].癌症,2002,21(4):360-363. 被引量：5
-
2王劲松,王深明,陈国锐,李晓曦,杨大俊.基因重组毒素HELβ1-PE38KDEL与顺铂杀伤乳腺癌细胞系的协同作用[J].中国癌症杂志,2002,12(1):35-37. 被引量：2
-
3王劲松,王深明,杨大俊,常光其,陈国锐.两种基因重组免疫毒素导向治疗乳腺癌的细胞毒活性研究[J].癌症,2001,20(11):1241-1245. 被引量：5
-
4Shi FS, Weber S, Gan J, et al. Granulocyte - macrophage colonystimulating factor(GM- CSF)secreted by eDNA- transfected tumor cells induces a more potent antitumor response than exogenous GM - CSF. Cancer Gene Ther, 1999,6 ( 1 ) : 81 - 88. 被引量：1
-
5Scholl SM, Balloul JM, Le - Goc G, et al. Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer. J I mmunother, 2000,23 (5) : 570 - 580. 被引量：1
-
6Obermiller PS, Tait D, Holt JT, et al. Gene therapy for carcinoma of the breast therapeutic genetic correction strategies. Breast Cancer Res,2000,2(1) -28 - 31. 被引量：1
-
7Gomez NJ, Arafat W, Xiang J. Gene therapy for carcinoma of the breast pro - apoptotic gene therapy. Breast Cancer Res, 2000, 2(1):32-44. 被引量：1
-
8Hortobagyi GN, Ueno NT,Xia W, et al. Catinoic liposome- mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol, 2001,19(14) :3422 - 3433. 被引量：1
-
9Cowan KH, Moscow JA, Huang H, et al. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA(MDR1 )in metastatic breast cancer patients. Clin Cancer Res, 1999,5(7) : 1619 - 1628. 被引量：1
-
10Pandha HS, Martin LA, Rigg A, et al. Genetic prodrug activation therapy for breast cancer:a phase I clinical trial of erbB- 2 - directed suicide gene expression. J Clin Oncol, 1999,17 (7) : 2180 -2189. 被引量：1
二级参考文献20
-
1Yang D，Clin Cancer Res，1998年，4卷，4期，993页 被引量：1
-
2Yang D,Kuan CT,Payne J,et al.Recombinant hereg ulin Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo [J].Clin Cancer Res,1998,4(4):993- 1004. 被引量：1
-
3Schmitt CA,Lowe SW.Apoptosis and therapy [J].J Pathol,1999,187(1):127- 137. 被引量：1
-
4Keppler Hafkemeyer A,Brinkmann U,Pastan I.Role of caspases in immunotoxin induced apoptosis of cancer cells [J].Biochemistry,1998,37(48):16934- 16942. 被引量：1
-
5Kaufmann SH,Desnoyers S,Ottaviano Y,et al.Specific proteolytic cleavage of poly(ADP ribose) polymerase: an early marker of chemotherapy induced apoptosis [J].Cancer Res,1993,53(17):3976- 3985. 被引量：1
-
6Aas T,Borresen AL,Geisler S,et al.Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients [J].Nat Med,1996,2(7):811- 814. 被引量：1
-
7Reed JC.Bcl 2 family proteins [J].Oncogene,1998,17(25):3225- 3236. 被引量：1
-
8Felip E,Del Campo JM,Rubio D,et al.Overexpression of c erbB 2 in epithelial ovarian cancer.Prognostic value and relationship with response to chemotherapy [J].Cancer,1995,75(8):2147- 2152. 被引量：1
-
9Muss HB,Thor AD,Berry DA,et al.c erbB 2 expression and response to adjuvant therapy in women with node positive early breast cancer [J].N Engl J Med,1994,330(18):1260-1266. 被引量：1
-
10Gordon LI;Harring D;Andersen J.Comparison of a second-generation combination chemotherapeutic regimen m-BACOD) with a standard regimen CHOP) for advanced diffuse non-Hodgkin's lymphoma[J],1992(19). 被引量：1
共引文献7
-
1苏玉华.顺铂治疗胃癌的临床研究进展[J].中国药事,2004,18(8):504-506. 被引量：1
-
2王深明,殷恒讳.乳腺癌基因治疗的现状与存在问题[J].中华医学杂志,2005,85(1):3-6. 被引量：1
-
3王深明,林颖.乳腺癌基因治疗进展[J].中华外科杂志,2006,44(1):55-58. 被引量：1
-
4高宝东.基因治疗乳腺癌[J].临床和实验医学杂志,2007,6(4):164-165. 被引量：1
-
5李艳.基因疗法治疗乳腺癌研究近况[J].实用中医药杂志,2010,26(7):510-511.
-
6刘雪花,董琳,侯小燕,庄英帜.芦荟多糖增强顺铂对肺腺癌裸鼠移植瘤生长的抑制作用[J].中国现代应用药学,2011,28(12):1080-1084. 被引量：3
-
7于勇,卢佃华,杜鹏程,苏玉华.顺铂治疗胃癌的临床应用进展[J].中国药师,2004,7(3):199-201. 被引量：2
-
1高宝东.基因治疗乳腺癌[J].临床和实验医学杂志,2007,6(4):164-165. 被引量：1
-
2赵英伦,陆绍龙,叶小龙,张庆梅,谢小薰.癌—睾丸抗原与结直肠癌关系的研究[J].广西医科大学学报,2015,32(2):326-328. 被引量：4
-
3王雪峰,刘晓谦,杨富明.胶质瘤基因治疗研究进展[J].国外医学（遗传学分册）,2003,26(2):79-82.
-
4宋炯,付仲学.肿瘤的抗血管生成基因治疗(文献综述)[J].国外医学（外科学分册）,2003,30(5):290-294. 被引量：2
-
5姚莉,卞修武.VEGF与肿瘤血管生成及抗血管生成基因治疗[J].国外医学（生理病理科学与临床分册）,1999,19(6):444-446. 被引量：8
-
6宫亮,杨和平.肺癌的抗血管生成基因治疗[J].中国肺癌杂志,2002,5(3):232-234.
-
7何小平,李兆申,屠振兴.胰腺癌抗肿瘤血管生成治疗[J].世界华人消化杂志,2004,12(10):2442-2445. 被引量：1
-
8周正波,刘奇,杨瑞森.肿瘤血管生成及抗血管生成基因治疗[J].国外医学（肿瘤学分册）,2001,28(2):116-117. 被引量：60
-
9张宁宁,薛妍,刘文超.肿瘤血管生成与抗血管生成基因治疗[J].中国肿瘤临床,2007,34(21):1253-1256. 被引量：4
-
10史光军,李占武,丁苏明.肿瘤抑癌基因p53与原发性肝癌[J].山东医药,2000,40(22):56-56.
